MedPath

Community Translation of the Expecting Study

Not Applicable
Conditions
Pregnancy Related
Registration Number
NCT04298125
Lead Sponsor
Arkansas Children's Hospital Research Institute
Brief Summary

The Expecting intervention as delivered in prior studies in a clinical setting is described in a previous approved IRB submission (Protocol 202954). The current project will seek to engage community stakeholders to translate Expecting to a community-delivered intervention and to test its acceptability, feasibility, and fidelity in a proof of principle study with 60 expecting mothers.

Detailed Description

The aim of this study is to adapt and determine acceptability, feasibility and fidelity of the research- clinic-based Expecting intervention with pregnant women with obesity in community settings. Specifically, the investigators will show effective application of the Replicating Effective Programs (REP) framework (e.g., fidelity, feasibility, acceptability) to translate the research clinic-based intervention to community settings. REP provides a four-phase process for implementing evidence-based interventions and has demonstrated effective application to translate clinical interventions to community settings. Built into the REP framework is the collection of feedback from community stakeholders, iterative piloting of the intervention in the community, and a process for standardizing the intervention across community settings. Following adaptation, the updated intervention will be piloted. The pilot study will include 60 expecting women. The investigators will randomize half to receive the community-adapted Expecting intervention (Intervention, N=30) and half to receive standard of care (Control, N=30).

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • (a) Body Mass Index > 30,
  • (b) singleton pregnancy,
  • (c) between 11-15 weeks of pregnancy (at enrollment),
  • (d) sedentary (do not engage in purposeful physical activity plus have sedentary work)
  • (e) cleared by physician
Exclusion Criteria
  • (a) contraindications for exercise (preeclampsia-eclampsia, premature rupture of the membranes, antepartum hemorrhage, placenta previa, multiple gestation and other defined conditions)
  • (b) illicit drug use.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Acceptability of Intervention Measure: 38 weeks38 weeks

Attitudinal Implementation Outcome on a 1 to 5 scale

Feasibility of Intervention Measure:38 weeks38 weeks

Attitudinal Implementation Outcome on a 1 to 5 scale

Secondary Outcome Measures
NameTimeMethod
Body Mass IndexChange from Baseline to Delivery and 6 Months Post Delivery

Collected from Medical Record, weight and height will be combined to report BMI in kg/m\^2

Total Cholesterol from Lipid PanelChange from Baseline to Delivery and 6 Months Post Delivery

Collected from Medical Record

Number of intervention sessions completed15 weeks through 38 weeks

Measured with attendance records

Blood PressureChange from Baseline to Delivery and 6 Months Post Delivery

Collected from Medical Record

Number of minutes of physical activityChange from Baseline to Delivery and 6 Months Post Delivery

Measured with Actical

Trial Locations

Locations (1)

Arkansas Children's Nutrition Center

🇺🇸

Little Rock, Arkansas, United States

Arkansas Children's Nutrition Center
🇺🇸Little Rock, Arkansas, United States
Taren M Swindle, PhD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.